» Articles » PMID: 37561316

A Scoping Review of Studies Exploring Physical Activity and Cognition Among Persons with Cancer

Overview
Journal J Cancer Surviv
Specialty Oncology
Date 2023 Aug 10
PMID 37561316
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: This scoping review aimed to identify and synthesize published studies on physical activity (PA) and cognition among persons with cancer and elucidate knowledge gaps.

Methods: Articles were identified through electronic and manual searches (02/21 and 03/22) using the following inclusion criteria: (1) empirical, peer-reviewed publication in English, (2) sample comprised persons with cancer, and (3) reported at least one statistical association between PA and cognition. Multiple reviewers independently performed study selection and data extraction, and results were mapped in tabular and narrative form.

Results: Ninety-seven articles were eligible; these were largely published from 2017 to 2022 (54.6%), conducted in high-income countries (96.9%), and presented (quasi-)experimental studies (73.2%). Samples predominantly comprised women with breast cancer (48.5%), and recruitment often occurred post-treatment (63.9%). PA interventions included: aerobic (32.3%), resistance (4.8%), combined aerobic/resistance (38.7%), mind-body (19.4%), or other PA (4.8%). Most (66%) articles reported inconclusive findings; 32% were positive (in support of PA promoting cognition or vice versa), and 2.1% were negative. Diverse samples and studies with long-term follow-up were scarce.

Conclusions: The state of knowledge is insufficient and more rigorous, large-scale studies are required to provide definitive conclusions about the cognitive benefits of PA among persons with cancer.

Implications For Cancer Survivors: Cancer-related cognitive impairment (CRCI) thwarts quality of life. This review summarizes what is known about the association between PA and cognition among persons with cancer and concludes that the evidence is currently equivocal. Hence, it remains uncertain if PA interventions can reduce CRCI, and large-scale PA intervention trials explicitly designed to promote cognition are greatly needed.

Citing Articles

A pilot study of a targeted cognitive intervention for cancer survivors.

Anguera J, Snowberg K, Paul S, Cooper B, Oppegaard K, Harris C Support Care Cancer. 2025; 33(4):255.

PMID: 40053154 PMC: 11889051. DOI: 10.1007/s00520-025-09321-z.


The effect of non-pharmacological interventions on cognitive function in cancer: an overview of systematic reviews.

Haywood D, Henneghan A, Chan A, Chan R, Dhillon H, Lustberg M Support Care Cancer. 2025; 33(2):151.

PMID: 39904905 PMC: 11794363. DOI: 10.1007/s00520-025-09212-3.


Relationship of physical activity and cognitive functioning among breast cancer survivors: a cross-sectional analysis.

Hartman S, Zablocki R, Tam R, Palmer B, Parker B, Sears D Front Cognit. 2024; 3.

PMID: 39483324 PMC: 11526472. DOI: 10.3389/fcogn.2024.1332960.


Aerobic exercise and CogniTIVe functioning in women with breAsT cancEr (ACTIVATE): A randomized controlled trial.

Brunet J, Sharma S, Zadravec K, Taljaard M, LeVasseur N, Srikanthan A Cancer. 2024; 131(1):e35540.

PMID: 39428863 PMC: 11694240. DOI: 10.1002/cncr.35540.


Bibliometric Analysis of Research on Exercise Intervention for Cancer-Related Cognitive Impairments.

Shen Y, Xu N, Yu T, Li J Healthcare (Basel). 2024; 12(19).

PMID: 39408155 PMC: 11475680. DOI: 10.3390/healthcare12191975.


References
1.
Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View

2.
Nayak M, George A, Vidyasagar M, Mathew S, Nayak S, Nayak B . Quality of Life among Cancer Patients. Indian J Palliat Care. 2017; 23(4):445-450. PMC: 5661349. DOI: 10.4103/IJPC.IJPC_82_17. View

3.
Lewandowska A, Rudzki G, Lewandowski T, Prochnicki M, Rudzki S, Laskowska B . Quality of Life of Cancer Patients Treated with Chemotherapy. Int J Environ Res Public Health. 2020; 17(19). PMC: 7579212. DOI: 10.3390/ijerph17196938. View

4.
Janelsins M, Kohli S, Mohile S, Usuki K, Ahles T, Morrow G . An update on cancer- and chemotherapy-related cognitive dysfunction: current status. Semin Oncol. 2011; 38(3):431-8. PMC: 3120018. DOI: 10.1053/j.seminoncol.2011.03.014. View

5.
Janelsins M, Kesler S, Ahles T, Morrow G . Prevalence, mechanisms, and management of cancer-related cognitive impairment. Int Rev Psychiatry. 2014; 26(1):102-13. PMC: 4084673. DOI: 10.3109/09540261.2013.864260. View